24.10

1.26% 0.30

Instil Bio Inc (TIL)

Overview News Price History Option Chain Financials Discussions Forecast

Instil Bio Inc stock is traded at $24.10, with a volume of 207.47K. It is up +1.26% in the last 24 hours and down -10.18% over the past month. Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

Previous Close:

$23.80

Open:

$23.37

24h Volume:

207.47K

Relative Volume:

0.96

Market Cap:

$162.69M

Revenue:

Net Income/Loss:

$-74.14M

P/E Ratio:

-2.1159

EPS:

-11.39

Net Cash Flow:

$-65.70M

1W Performance:

-23.49%

1M Performance:

-10.18%

6M Performance:

+33.22%

1Y Performance:

-48.13%

1-Day Range:

$23.37

$25.50

1-Week Range:

$22.67

$30.50

52-Week Range:

$10.80

$92.00

Instil Bio Inc Stock (TIL) Company Profile

Name

Instil Bio Inc

Sector

Healthcare (1152)

Industry

Biotechnology (648)

Phone

(972) 499-3350

Address

3963 MAPLE AVENUE, DALLAS

Employee

Twitter

Next Earnings Date

2024-11-11

Latest SEC Filings

TIL's Discussions on Twitter

Compare TIL with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TIL Instil Bio Inc	24.10	155.13M	0	-74.14M	-65.70M	-11.39
VRTX Vertex Pharmaceuticals Inc	394.53	99.62B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	465.89	61.52B	2.46B	-319.09M	-52.09M	-2.47
REGN Regeneron Pharmaceuticals Inc	560.00	58.91B	14.21B	4.46B	3.56B	39.68
ARGX Argen X Se Adr	756.38	46.69B	3.06B	1.28B	447.35M	21.30
ONC Beone Medicines Ltd Adr	324.34	34.54B	3.81B	-644.79M	-669.77M	-6.24

Instil Bio Inc Stock (TIL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-07-25	Upgrade	Jefferies	Hold → Buy
Nov-04-24	Initiated	JMP Securities	Mkt Perform
Apr-12-24	Downgrade	Jefferies	Buy → Hold
Nov-01-22	Downgrade	Cowen	Outperform → Market Perform
Nov-01-22	Downgrade	Truist	Buy → Hold
Aug-13-21	Initiated	Robert W. Baird	Outperform
Apr-13-21	Initiated	Cowen	Outperform
Apr-13-21	Initiated	Morgan Stanley	Equal-Weight
Apr-13-21	Initiated	Truist	Buy

View All

Instil Bio Inc Stock (TIL) Latest News

07:11 AM

Is now a turning point for Instil Bio Inc.Portfolio Update Summary & Stepwise Entry/Exit Trade Alerts - Newser

07:11 AM

Instil Bio Inc (TIL)

Instil Bio Inc Stock (TIL) Company Profile

Compare TIL with other stocks

Instil Bio Inc Stock (TIL) Upgrades & Downgrades

Instil Bio Inc Stock (TIL) Latest News

Is now a turning point for Instil Bio Inc.Portfolio Update Summary & Stepwise Entry/Exit Trade Alerts - Newser

Has Instil Bio Inc. formed a bullish divergenceShort Setup & Accurate Entry/Exit Alerts - Newser

Will breakout in Instil Bio Inc. lead to full recoveryJuly 2025 Breakouts & Weekly Watchlist of Top Performers - Newser

Predicting Instil Bio Inc. trend using moving averages2025 Investor Takeaways & Weekly High Momentum Picks - Newser

Applying Elliott Wave Theory to Instil Bio Inc.2025 Trade Ideas & Daily Oversold Stock Bounce Ideas - Newser

News impact scoring models applied to Instil Bio Inc.July 2025 Short Interest & Risk Controlled Swing Alerts - Newser

How to build a dashboard for Instil Bio Inc. stock2025 Analyst Calls & Low Volatility Stock Suggestions - Newser

Risk adjusted return profile for Instil Bio Inc. analyzedMarket Activity Report & Fast Moving Stock Watchlists - Newser

What data driven models say about Instil Bio Inc.’s futureGap Up & Fast Entry Momentum Trade Alerts - Newser

What institutional flow reveals about Instil Bio Inc.Market Performance Report & Technical Pattern Recognition Alerts - Newser

Instil Bio stock rating reiterated at Buy by H.C. Wainwright - Investing.com

Will Instil Bio Inc. stock recover after recent dropGold Moves & Real-Time Price Movement Reports - Newser

Strategies to average down on Instil Bio Inc.Quarterly Profit Review & Long-Term Growth Stock Strategies - Newser

Using data models to predict Instil Bio Inc. stock movementStop Loss & High Accuracy Swing Entry Alerts - Newser

Can volume confirm reversal in Instil Bio Inc.2025 Volume Leaders & Weekly Stock Performance Updates - Newser

Can trapped investors hope for a rebound in Instil Bio Inc.Wall Street Watch & Long-Term Capital Growth Strategies - Newser

Is Instil Bio Inc. stock poised for growthQuarterly Portfolio Report & AI Enhanced Trade Execution Alerts - Newser

Will earnings trigger a reversal in Instil Bio Inc.Bond Market & Reliable Price Breakout Signals - Newser

Order flow analysis tools used on Instil Bio Inc.July 2025 Patterns & Free Fast Entry Momentum Trade Alerts - Newser

Should you hold or exit Instil Bio Inc. now2025 Trade Ideas & Smart Swing Trading Techniques - Newser

Risk vs reward if holding onto Instil Bio Inc.Market Performance Recap & Technical Confirmation Trade Alerts - Newser

Price action breakdown for Instil Bio Inc.2025 Trade Ideas & Consistent Growth Equity Picks - Newser

Instil Bio Announces ImmuneOnco’s Presentation of ‘2510 - GlobeNewswire

35% Treatment Response: Instil Bio's Novel Cancer Drug Shows Promise in Advanced Lung Cancer Patients - Stock Titan

Combining machine learning predictions for Instil Bio Inc.2025 Major Catalysts & Real-Time Price Movement Reports - Newser

Real time breakdown of Instil Bio Inc. stock performanceEarnings Risk Report & Free Real-Time Volume Trigger Notifications - Newser

Identifying reversal signals in Instil Bio Inc.IPO Watch & Risk Managed Investment Signals - Newser

How to interpret RSI for Instil Bio Inc. stockJuly 2025 Market Mood & Low Risk High Reward Trade Ideas - Newser

Instil Bio Inc Stock (TIL) Financials Data

Revenue

Net Income

Cash Flow

EPS

Instil Bio Inc Stock (TIL) Insider Trading

Similar to TIL